LEO Pharma’s innovation engine is fuelled by a global R&D organisation with more than 700 curious, expert scientists and specialists. Together with business development acquisitions and partnerships, we have built a substantial pipeline focused on covering several indications. By focusing on driving medical dermatology forward we are expanding our internal innovation and external partnerships to ensure we deliver on our highly ambitious R&D commitments.

LEO Pharma Colleagues working at desk

Our current pipeline includes:

  • LP0162
  • LP0133
  • LP0155
  • LP0145
  • LP0058
  • LP0190
  • LP0184

In addition, we explore opportunities to make treatment easier for patients through innovations within medical device technologies and digital solutions and services.

Cookies on this site

LEO Laboratories Limited uses cookies to give you the best experience online and to provide anonymised, aggregated site usage data. You can find out what cookies we use, what they do and how you can disable them in our Cookie Policy. By browsing our sites, you consent to the use of cookies. If you want to know more about our cookie policy and how to avoid and delete cookies click here. By continuing to browse this site, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.